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background: Studies have suggested that cardiac resynchronization therapy (CRT) improves the renal function during long term follow up in heart 
failure (HF) patients with ventricular dyssynchrony, possibly mediated by improvement in cardiac function. We hypothesized that CRT results in acute 
improvement in glomerular filtration rate (GFR) as calculated by MDRD equation on the post-implantation day.
Methods: We performed a retrospective chart review of patients receiving CRT at the Methodist Healthcare System, Memphis TN. A total of 100 
patients who successfully received CRT, and had serum creatinine checked on the day of the procedure as well as on the post-implantation day were 
included. A control group of 100 patients receiving only implantable cardioverter defibrillator (ICD) but no coronary sinus lead was also studied.
results: The characteristics of the CRT group were as follows: mean age 67 ±15 years, 68% male, mean left ventricular ejection fraction (LVEF) 24± 
5%, mean QRS duration 145 ± 25ms, average contrast use 47 ± 37 ml. The control ICD group had following characteristics: mean age 69 ±16 years, 
70% male, mean LVEF 30 ± 14%, average contrast use 3.5 ± 14 ml. On the post-implantation day in the CRT group, 43 % patients had improvement 
in their GFR, 43% had no change, and 14 % had decline in GFR. The mean GFR in the CRT group improved by 4.2% from a mean of 72 ± 41 mL/
min to 75 ± 43 mL/min (P=.18). There was a 12.5% improvement in GFR in 39/100 patients in the CRT group with baseline GFR <60 mL/min from 
40±13 mL/min to 45 ± 16 mL/min (p=0.0001). In the control ICD group, 12 % patients had improvement in their GFR, 44% had no change, and 
44% had decline in GFR. The mean GFR decreased by 8.3% from 84 ± 44.3 mL/min to 77.06 ± 38.7 mL/min (p=0.0001).
conclusions:  CRT improves the GFR in HF patients with decreased renal function on the post-implantation date. Therefore CRT should not be 
delayed for eligible HF candidates with renal dysfunction, as is sometimes seen in clinical practice due to concerns for contrast nephropathy.
introduction: Renal insufficiency in the setting of heart failure has an increased association of mortality and morbidity and appropriate 
management of RI may well be a strategy to improve HF outcomes
